HomeCNSP • NASDAQ
Follow
CNS Pharmaceuticals Inc
Previous close
$0.21
Day range
$0.19 - $0.21
Year range
$0.19 - $3.35
Market cap
2.16M USD
Avg Volume
240.39K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.38M | 4.77% |
Net income | -5.38M | -4.64% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.38M | -4.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 548.72K | -94.54% |
Total assets | 1.70M | -86.97% |
Total liabilities | 6.13M | 24.65% |
Total equity | -4.43M | — |
Shares outstanding | 10.63M | — |
Price to book | -0.30 | — |
Return on assets | -667.60% | — |
Return on capital | 461.34% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -5.38M | -4.64% |
Cash from operations | -2.54M | -10.02% |
Cash from investing | -2.16K | -215,800.00% |
Cash from financing | 2.18M | -59.17% |
Net change in cash | -360.83K | -111.92% |
Free cash flow | -1.22M | -955.02% |
About
Founded
2017
Headquarters
Website
Employees
3